Myeloperoxidase-immunoreactive cells are significantly increased in brain areas affected by neurodegeneration in Parkinson’s and Alzheimer’s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0878
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Myeloperoxidase-immunoreactive cells are significantly increased in brain areas affected by neurodegeneration in Parkinson’s and Alzheimer’s disease ; day:2 ; month:5 ; year:2017 ; pages:1-10
Cell & tissue research ; (2.5.2017), 1-10
- Keyword
-
Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit
- Creator
-
Gellhaar, Sandra
- Contributor
-
Sunnemark, Dan
Eriksson, H°akan
Olson, Lars
Galter, Dagmar
SpringerLink (Online service)
- DOI
-
10.1007/s00441-017-2626-8
- URN
-
urn:nbn:de:1111-201705182623
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gellhaar, Sandra
- Sunnemark, Dan
- Eriksson, H°akan
- Olson, Lars
- Galter, Dagmar
- SpringerLink (Online service)
Other Objects (12)
Parkinson's and Alzheimer's today : about neurodegeneration and its therapy
Parkinson’s disease and Alzheimer’s disease: a Mendelian randomization study
Modeling the neuroimmune system in Alzheimer’s and Parkinson’s diseases
The aging immune system in Alzheimer’s and Parkinson’s diseases
Alzheimer, Parkinson und andere Alterskrankheiten
Parkinson und Alzheimer heute : was wir über Neurodegeneration und ihre Therapie wissen
Comparing Alzheimer’s and Parkinson’s diseases networks using graph communities structure
Facial emotion expressivity in patients with Parkinson’s and Alzheimer’s disease
The human olfactory system in two proteinopathies: Alzheimer’s and Parkinson’s diseases
Development of seed amplificafion assays as biomarkers for Alzheimer’s & Parkinson’s disease
Circulatory miR-223-3p Discriminates Between Parkinson’s and Alzheimer’s Patients
Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease
Parkinson's and Alzheimer's today : about neurodegeneration and its therapy
Parkinson’s disease and Alzheimer’s disease: a Mendelian randomization study
Modeling the neuroimmune system in Alzheimer’s and Parkinson’s diseases
The aging immune system in Alzheimer’s and Parkinson’s diseases
Alzheimer, Parkinson und andere Alterskrankheiten
Parkinson und Alzheimer heute : was wir über Neurodegeneration und ihre Therapie wissen
Comparing Alzheimer’s and Parkinson’s diseases networks using graph communities structure
Facial emotion expressivity in patients with Parkinson’s and Alzheimer’s disease
The human olfactory system in two proteinopathies: Alzheimer’s and Parkinson’s diseases
Development of seed amplificafion assays as biomarkers for Alzheimer’s & Parkinson’s disease
Circulatory miR-223-3p Discriminates Between Parkinson’s and Alzheimer’s Patients
Alzheimer’s disease tau is a prominent pathology in LRRK2 Parkinson’s disease
Parkinson's and Alzheimer's today : about neurodegeneration and its therapy
Parkinson’s disease and Alzheimer’s disease: a Mendelian randomization study
Modeling the neuroimmune system in Alzheimer’s and Parkinson’s diseases
The aging immune system in Alzheimer’s and Parkinson’s diseases
Alzheimer, Parkinson und andere Alterskrankheiten
Parkinson und Alzheimer heute : was wir über Neurodegeneration und ihre Therapie wissen
Comparing Alzheimer’s and Parkinson’s diseases networks using graph communities structure
Facial emotion expressivity in patients with Parkinson’s and Alzheimer’s disease
The human olfactory system in two proteinopathies: Alzheimer’s and Parkinson’s diseases
Development of seed amplificafion assays as biomarkers for Alzheimer’s & Parkinson’s disease
Circulatory miR-223-3p Discriminates Between Parkinson’s and Alzheimer’s Patients